FDA Drug Application (021093) for ATACAND HCT by ASTRAZENECA

Back to FDA Applications sponsored by ASTRAZENECA

Application Number021093
Product Number001
FormTABLET;ORAL
Dosage16MG;12.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameATACAND HCT
Active IngredientCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient CANDESARTAN CILEXETIL5
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by ASTRAZENECA